[Objectivation of the pharmacodynamic effect of a new parasympatholytic by means of hypotonic duodenography].
D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004386:Duodenum / Q000000981:diagnostic imaging*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008722:Methods; D008875:Middle Aged; D010276:Parasympatholytics / Q000009:adverse effects / Q000494:pharmacology*; D011708:Pylorus / Q000187:drug effects; D011759:Pyrrolidines / Q000009:adverse effects / Q000494:pharmacology*; D011859:Radiography; D013141:Spiro Compounds / Q000009:adverse effects / Q000494:pharmacology*; D013268:Stimulation, Chemical
D010276:Parasympatholytics; D011759:Pyrrolidines; D013141:Spiro Compounds
Objektivierung der pharmakodynamischen Wirkung eines neuen Parasympathicolyticums mittels hypotoner Duodenographie.